Cytosorbents (CTSO) EBITDA Margin (2011 - 2026)
Cytosorbents (CTSO) reported EBITDA Margin of 34.34% for Q1 2026, up 1021.0% on a YoY basis from 3.06% in Q1 2025, and up 27.68% quarter-over-quarter from 47.49% in Q4 2025.
Cytosorbents (CTSO) EBITDA Margin (2011 - 2026) Analysis & Trends
Cytosorbents has reported EBITDA Margin for 16 years, with the latest figure at 34.34% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 1021.0% year-over-year to 34.34%; the trailing twelve-month figure through Mar 2026 stood at 37.38% (up 700.0% YoY), and the FY2025 full-year result was 39.79%, up 643.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 34.34%, up from 47.49% in the prior quarter.
- The five-year high for EBITDA Margin was 30.17% in Q3 2025, with the low at 111.17% in Q3 2022.
- Historically, EBITDA Margin has averaged 64.2% across 5 years, with a median of 56.08% in 2024.
- Annual changes were most pronounced in 2022 — EBITDA Margin plunged 6273 bps — and 2024, when it soared 7144 bps.
- Cytosorbents' EBITDA Margin stood at 67.69% in 2022, then sank by 60 bps to 108.54% in 2023, then jumped by 66 bps to 37.1% in 2024, then fell by 28 bps to 47.49% in 2025, then gained by 28 bps to 34.34% in 2026.
- The last three EBITDA Margin figures came in at 34.34% (Q1 2026), 47.49% (Q4 2025), and 30.17% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 28.97% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 10.04% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 21.42% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 19.94% |
| 10 | Cytosorbents | 25.72 Mn | 20.92 Mn | 6.13 Mn | -34.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.34% |
| Dec 31, 2025 | -47.49% |
| Sep 30, 2025 | -30.17% |
| Jun 30, 2025 | -37.59% |
| Mar 31, 2025 | -44.55% |
| Dec 31, 2024 | -37.10% |
| Sep 30, 2024 | -56.08% |
| Jun 30, 2024 | -40.38% |
| Mar 31, 2024 | -51.80% |
| Dec 31, 2023 | -108.54% |
| Sep 30, 2023 | -83.42% |
| Jun 30, 2023 | -69.62% |
| Mar 31, 2023 | -83.51% |
| Dec 31, 2022 | -67.69% |
| Sep 30, 2022 | -111.17% |
| Jun 30, 2022 | -98.37% |
| Mar 31, 2022 | -89.64% |
| Dec 31, 2021 | -88.68% |
| Sep 30, 2021 | -55.39% |
| Jun 30, 2021 | -40.96% |